Philadelphia has not been traditionally known as a leading hub for biotechnology innovation and commercialization, in contrast to those hubs located Boston and San Francisco. However, the city is hoping that the more than 16,000 delegates attending the BIO 2019 International Convention this week will learn just how much research and development is taking place and that global recognition for its foundational research in gene and cell therapy has earned it the name of "Cellicon Valley." Read More
The American Society of Clinical Oncology (ASCO) annual meeting, which opened in Chicago late last week, is closely watched by analysts and investors alike, and favorable data presented at the event can advance a company's stock valuation significantly. Equally, candidate cancer therapies that do not live up to expectations will see their developers face the ire of investors. Read More